Colorectal Cancer _ ___________________________________________________________________________ 175. Burt RW. Familial risk and colorectal cancer. Gastroenterol Clin North Am . 1996;25(4):793-803. 176. Kang H, O’Connell JB, Leonardi MJ, Maggard MA, Mcgory ML, Ko CY. Rare tumors of the colon and rectum: a national review. Int J Colorectal Dis . 2007;22(2):183-189. 177. Arnold CN, Goel A, Blum HE, Boland CR. Molecular pathogenesis of colorectal cancer. Cancer . 2005;104(10):2035-2047. 178. Wu K, Keum N, Nishihara R, Giovannucci EL. Cancers of the colon and rectum. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D (eds). Cancer Epidemiology and Prevention . 4th ed. New York, NY: Oxford University Press; 2018: 681-706. 179. Manne U, Shanmugam C, Katkoori VR, Bumpers HL, Grizzle WE. Development and progression of colorectal neoplasia. Cancer Biomark . 2010;9(1-6):235-265. 180. Shah NB, Lindor NM. Lower gastrointestinal tract cancer predisposition syndromes. Hematol Oncol Clin North Am . 2010;24(6):1229- 1252. 181. Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice. Gut . 2011;60(1):116-129. 182. De Jong AE, Morreau H, Van Puijenbroek M, et al. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology . 2004;126(1):42-48. 183. Grizzle WE, Srivastava S, Manne U. The biology of incipient, pre-invasive or intraepithelial neoplasia. Cancer Biomark . 2011;9 (1-6):21- 39. 184. Reeves HL, Narla G, Ogunbiyi O, et al. Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gastroenterology . 2004;126(4):1090-1103. 185. Gonsalves WI, Mahoney MR, Sargent DJ, et al. Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance No. 147. J Natl Cancer Inst . 2014;106(7):dju106. 186. Sideris M, Papagrigoriadis S. Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer. Anticancer Res . 2014;34(5):2061-2068. 187. Monson JRT, Weiser MR, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum . 2013;56(5):535-550. 188. Chang GJ, Kaiser AM, Mills S, et al. Practice parameters for the management of colon cancer. Dis Colon Rectum . 2012;55:831-843. 189. Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta- analysis. Eur J Cancer. 2006;42(2):216-227. 190. Kanellos D, Kitsios G, Kanellos I, et al. Anemia as a symptom of right colon cancer. Tech Coloproctol . 2004;8(Suppl 1):S62-S64. 191. du Toit J, Hamilton W, Barraclough K. Risk in primary care of colorectal cancer from new onset rectal bleeding: 10 year prospective study. BMJ . 2006;333(7558):69-70. 192. Fisher SE, Daniels LR. The clinical presentation of colorectal cancer. In: Brown G (ed). Colorectal Cancer: Contemporary Issues in Cancer Imaging . Cambridge: Cambridge University Press; 2008: 1-14. 193. Halligan S, Wooldrage K, Dadswell E, et al. Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial. Lancet . 2013;381(9873):1185-1193. 194. Atkin W, Dadswell E, Wooldrage K, et al. Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet . 2013;381(9873):1194-1202. 195. ASGE Standards of Practice Committee, Fisher DA, Shergill AK, et al. Role of endoscopy in the staging and management of colorectal cancer. Gastrointest Endosc . 2013;78(1):8-12. 196. Ganeshan A, Upponi S, Uberoi R, D’Costa H, Picking C, Bungay H. Minimal-preparation CT colon in detection of colonic cancer, the Oxford experience. Age Ageing . 2007;36(1):48-52. 197. Kealey SM, Dodd JD, MacEneaney PM, Gibney RG, Malone DE. Minimal preparation computed tomography instead of barium enema/colonoscopy for suspected colon cancer in frail elderly patients: an outcome analysis study. Clin Radiol . 2004;59(1):44-52. 198. Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol . 2012;19(7):2212-2223. 199. Zhang C, Chen Y, Xue H, et al. Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis. Int J Cancer . 2009;124(1):167-173. 200. Kennedy E, Vella E, MacDonald DB, Wong CS, McLeod R. Optimization of preoperative assessment in patients diagnosed with rectal cancer. Clin Oncol (R Coll Radiol) . 2015;27(4):225-245. 201. National Cancer Institute. Colon Cancer Treatment: Health Professional Version. Available at https://www.cancer.gov/types/ colorectal/hp/colon-treatment-pdq. Last accessed March 7, 2022. 202. Amin MB, Edge SB, Greene F, et al. (eds). AJCC Cancer Staging Manual . 8th ed. New York, NY: Springer; 2018. 203. American Joint Committee on Cancer. Cancer Staging System. Available at https://www.facs.org/quality-programs/cancer/ajcc/ cancer-staging.What-is-Cancer-Staging.aspx. Last accessed March 7, 2022.
Powered by FlippingBook